Enhancing AAV Manufacturing Yield Through a Promoter-Optimized Mini-Helper Plasmid

Discover how a simple redesign of the AAV helper plasmid could make gene therapy manufacturing more efficient and cost-effective.

In this webinar, Samsung Biologics shares how its promoter-optimized mini-helper plasmid delivers up to a 6.5-fold increase in AAV yield, reduces DNA synthesis costs, and maintains high particle quality from lab scale to bioreactor production.

You’ll gain practical insights into the platform’s design, transfection optimization, and its potential to enable next-generation AAV manufacturing strategies.